Pfizer Inc agreed on Wednesday to purchase Baxter International Inc's vaccines unit and a part of a production facility for $635 million.The deal will give Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and its encephalitis vaccine, FSME-IMMUN.Pfizer will also get access to a portion of Baxter's facility in Austria where the vaccines are made.The deal is expected to close by the end of the year.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 1.3% or $-0.3837/share to $29.09. In the past year, the shares have traded as low as $27.76 and as high as $32.96. On average, 26444600 shares of PFE exchange hands on a given day and today's volume is recorded at 9690115.
Source
